4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001209191-23-022369
Chief Business Officer sold 9,036 shares at $26.52 ($239,643)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2023-03-30 | Sale 10b5-1 | −9,036 | $26.52 | $239,643 | 201,964 | D |
| Open-market sales · 9,036 sh · avg $26.52 · $239,643 | |||||||
Loading xslF345X04/doc4.xml…